Loading clinical trials...
Loading clinical trials...
Proof-of-concept Case-control Study for Colorectal Cancer Assessment Using Delta-HLD Technology (CASCADE)
Conditions
Locations
1
Argentina
Epiliquid
Mendoza, Argentina
Start Date
June 30, 2021
Primary Completion Date
August 1, 2025
Completion Date
December 1, 2026
Last Updated
August 29, 2025
NCT06332274
NCT04291105
NCT05022030
NCT06865521
NCT07342998
NCT07000474
Lead Sponsor
Epiliquid Holding, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions